Utang jangka cendhak perusahaan Organovo Holdings Inc. (VIVS)

VivoSim Labs Inc (VIVS) creates high-precision 3D organ models for pharmaceutical giants, minimizing risks during the testing of new drugs. The price indicator on the chart, with a value of 0.00, links the brand's scientific authority with a streamlined express delivery system for live cells that maintains strict temperature control. Business development relies on the implementation of bioprinted liver structures for toxicological analysis, demonstrating impressive research results.

VIVS Utang jangka cendhak VivoSim Labs (25.04.2025 - 31.10.2026)

Organovo (VIVS) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:

Rega saham VivoSim Labs Inc|VIVS - Rentang target analis

- rincian kapitalisasi pasar:

Nilai pasar Organovo Holdings|VIVS - Nilai Bisnis

- data nilai buku modal saham:

Aset Bersih saben Siji Saham Organovo|VIVS - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku organovo.com|VIVS - Gunggung Aset Perusahaan

- indikator beban utang lan likuiditas:

Rasio Total Utang marang Ekuitas VivoSim Labs Inc|VIVS - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Organovo Holdings|VIVS - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Organovo Holdings|VIVS - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Organovo|Likuiditas cepet organovo.com

- data bathi lan kelipatan valuasi:

VIVS - Penghasilan resik

Analisis fundamental perusahaan:Organovo Holdings Inc. (VIVS)

This indicator determines the financial stability of VivoSim Labs Inc (VIVS) through the volume of liabilities maturing within one year, allowing investors to assess liquidity and default risks in real time. By analyzing the short-term debt structure, one can understand how VivoSim Labs Inc balances its credit load to maintain the complex logistics of bioprinters and precision equipment, thereby ensuring the continuity of medical supplies.

Analisis pesaing